Large Cap Archives - Page 352 of 437

1 minute read

AbbVie Can Write Diversified Growth Story Without Humira, Rest Of The Business Has Strength, Analyst Says

March 1, 3:57 PM

Guggenheim initiated coverage on AbbVie Inc (NYSE:ABBV) with a Buy and a price target of $172 on diversified growth. Investors have “naturally” been…

ABBV

2 minute read

Housing Market Correction: Rates Up, Lack Of Buyers, Cracks Forming In Home Improvement

By AJ Fabino

March 1, 1:03 PM

The housing market, still in its relentless rough patch as mortgage rates continue to climb higher, is deterring buyers from making a move.

JPM

1 minute read

After Shelving Two Keytruda Trials, Merck Touts Encouraging Data From Keytruda Regime Study In Lung Cancer Patients

By Vandana Singh

March 1, 12:29 PM

Merck & Co Inc’s (NYSE:MRK) Phase 3 KEYNOTE-671 trial investigating Keytruda met one of its dual primary endpoints, event-free survival…

MRK

1 minute read

Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection

By Vandana Singh

March 1, 11:54 AM

Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain.

CDTX

1 minute read

FDA AdComm Gives Thumbs Up To Pfizer’s RSV Vaccine Candidate For Elderly People

By Vandana Singh

March 1, 11:36 AM

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of Pfizer Inc’s (NYSE:PFE) available data is adequate to…

PFE

1 minute read

FDA Approves Regeneron-Sanofi’s Sarilumab As First Biologic For Stiffness, Pain In Muscles

By Vandana Singh

March 1, 11:28 AM

The FDA approved Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Kevzara (sarilumab) for polymyalgia rheumatica (PMR), an inflammatory rheumatic disease, The approval…

REGN

2 minute read

Novavax Ushers New CEO On Uncertainty Concerns, Says It Needs To Work On Competitive COVID-19 Product

By Vandana Singh

March 1, 9:19 AM

COVID-19 vaccine maker Novavax Inc (NASDAQ: NVAX) shares plunged after it

NVAX

2 minute read

Can Ross Stores Keep Up With Retail Giants Target And Walmart? We’ll See At Market Close

By AJ Fabino

February 28, 2:11 PM

As retailers continue to report their earnings for the fourth quarter of 2022, investors are waiting for the upcoming earnings report from Ross Stores (NASDAQ: ROST), which is set to issue its fourth quarter results after market close on Tuesday<

ROST

1 minute read

Merck Discontinues Two Keytruda Combo Therapy Trials In Prostate & Lung Cancer Settings

By Vandana Singh

February 28, 12:39 PM

Merck & Co Inc (NYSE:MRK) is discontinuing the Phase 3 KEYNOTE-641 trial evaluating Keytruda (pembrolizumab) in combination with enzalutamide and androgen…

MRK

3 minute read

Would Tesla Start Paying Dividends If This Happened?

By AJ Fabino

February 28, 11:06 AM

As Tesla Inc (NASDAQ: TSLA)'s valuation continues to soar, doubling from January lows, and investors flock to the electric vehicle maker, some are wondering if the company will finally start paying dividends.

AAPL